Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 1;24(1):345.
doi: 10.1186/s12906-024-04632-w.

Bioassay-guided isolation and structure elucidation of anti-mycobacterium tuberculosis compounds from Galatella grimmii (Regel & Schmalh.) Sennikov

Affiliations

Bioassay-guided isolation and structure elucidation of anti-mycobacterium tuberculosis compounds from Galatella grimmii (Regel & Schmalh.) Sennikov

Abolfazl Shakeri et al. BMC Complement Med Ther. .

Abstract

Background: Galatella is a genus in the family Asteraceae, represented by 35-45 species. Considering the high effectiveness of the ethyl acetate (EtOAc) fraction of G. grimmii against Mycobacterium tuberculosis (MIC = 0.5 µg/mL), a bioassay-directed fractionation of this extract was carried out.

Methods: The methanolic extract of the aerial parts of G. grimmii was obtained using maceration, then it was suspended in water and partitioned with petroleum ether, dichloromethane (CH2Cl2), EtOAc, and n-butanol (n-BuOH), successively. The most potent fraction (EtOAc), was selected for further isolation by Sephadex LH-20 and semi-preparative HPLC to obtain active compounds.

Results: Fractionation of the EtOAc solvent fraction resulted in the characterization of five compounds, among them, compounds 1 and 2 showed the highest anti-mycobacterial effects with MICs of 0.062 and 1.00 µg/mL against H37Rv M. tuberculosis, respectively, which were higher than those of rifampin (MIC of 1.25 µg/mL) and isoniazid (MIC of 0.31 µg/mL), as positive controls. Also, compound 1 ​​inhibited all tested strains of drug-resistant Mycobacterium (MDR and XDR). Notably, the isolated compounds have been reported for the first time from G. grimmii.

Conclusion: Due to the potent anti-mycobacterial effect of isolated compounds from G. grimmii, this study could pave the way for developing a novel class of natural anti-tuberculosis compounds.

Keywords: Galatella; Mycobactrium Tuberculosis; Bioassay-guided fractionation; Flavonoids; NMR.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Flow chart of bioassay-guided fractionation of anti-TB comounds from G. grimmii
Fig. 2
Fig. 2
Chemical structures of isolated compounds

Similar articles

References

    1. Tuberculosis. Https://www.who.int/news-room/fact-sheets/detail/tuberculosis. 2022.
    1. Alsayed SSR, Gunosewoyo H, Tuberculosis. Pathogenesis, current treatment regimens and new drug targets. Int J Mol Sci. 2023;24(6):5202–025. - PMC - PubMed
    1. Seung KJ, Keshavjee S, Rich ML. Multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis. Cold Spring Harb Perspect Med. 2015;5(9):a017863–82. - PMC - PubMed
    1. Chakraborty S, Rhee KY. Tuberculosis Drug Development: history and evolution of the mechanism-based paradigm. Cold Spring Harb Perspect Med. 2015;5(8):a021147–58. - PMC - PubMed
    1. Singh KP, Carvalho ACC, Centis R, Migliori LDA, Mpagama GB. Clinical standards for the management of adverse effects during treatment for TB. Int J Tuberc Lung Dis. 2023;27(7):506–19. - PMC - PubMed

MeSH terms

LinkOut - more resources